Support Advancements in Research

617-573-3345

or Use Our Simple Online Form to Give Us Feedback

We welcome your comments and feedback. Please include contact information if you'd like a response.

Did you find this page helpful?





If you would like a response, please include your contact information.

Title
Biochemical, Genetic and Epidemiological Studies of Uveal Melanoma

 

MEEI Protocol ID
94-07-028
National Clinical Trial (NCT) Number
 
Condition
Uveal Melanoma
Sponsor
Massachusetts Eye and Ear Infirmary
Principal Investigator
Evangelos Gragoudas, M.D. and Ivana Kim, M.D.
Study Design
This is a prospective epidemiological research study.
Study Objective
To identify risk factors for the onset and progression of uveal melanoma, an intraocular cancer that threatens both sight and life. Additionally, to identify biomarkers that predict response to treatment.
Who is Eligible
Individuals who have been newly diagnosed with uveal melanoma.
Subject Enrollment
We are currently enrolling individuals with eye melanoma who meet the study eligibility criteria.
Study Procedures
Qualified patients will provide blood specimens that will be stored and used for future analyses of clinical, genetic and molecular markers of uveal melanoma. Clinical data will also be obtained at the time of diagnosis and at regular intervals after diagnosis. Tumor tissue specimens will be obtained from patients who have the eye removed (called enucleation). These analyses will enhance our ability to develop measures that may reduce disease incidence and improve survival.
For More Information
Edward Miretsky, Study Coordinator
617-573-4382

  

Click here to return to the Ophthalmology Clinical Research page.